Unique Ingredient Identifier 94255I6E2T is listed as a ingredient substance
| RN | 10028-24-7 |
| NCIT | C66547 |
| RXCUI | 1311323 |
| PUBCHEM | 6451167 |
| MF | 2Na.HO4P.2H2O |
| INCHI KEY | KDQPSPMLNJTZAL-UHFFFAOYSA-L |
| SMILES | O.O.[Na+].[Na+].OP([O-])([O-])=O |
UNII 94255I6E2T SODIUM PHOSPHATE, DIBASIC, DIHYDRATE is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| IM - IV | INJECTION | NA |
| INTRAVENOUS | INJECTABLE | 0.24 % |
| INTRAVENOUS | INJECTION | 0.15 % |
| INTRAVENOUS | SOLUTION, INJECTION | 1.09 % |
| IV - SC | INJECTION, SOLUTION | 0.53 MG/1ML |
| IV(INFUSION) | INJECTION | 0.013 % |
| NASAL | SPRAY | 3 MG/1ML |
| NASAL | SPRAY, METERED | 0.3 % |
| OPHTHALMIC | SOLUTION | 1.2 % |
| OPHTHALMIC | SOLUTION, DROPS | 1.2 % |
| OPHTHALMIC | SOLUTION/DROPS | 0.095 % |
| ORAL | CAPSULE | 0.9 MG |
| ORAL | CAPSULE, DELAYED ACTION | 2 MG |
| ORAL | CAPSULE, ENTERIC COATED PELLETS | 0.9 MG |
| ORAL | POWDER, FOR SOLUTION | NA |
| ORAL | SOLUTION | 2.5 MG/1ML |
| ORAL | SUSPENSION | 8 MG/1ML |
| SUBCUTANEOUS | INJECTABLE | 0.18 % |
| SUBCUTANEOUS | INJECTION | 0.15 % |
| SUBCUTANEOUS | INJECTION, SOLUTION | 1.42 MG/1ML |
| SUBCUTANEOUS | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | 0.11 % |
| SUBCUTANEOUS | SOLUTION, INJECTION | 0.047 % |
| SUBCUTANEOUS | SUSPENSION, INJECTION | 0.13 % |
| TOPICAL | EMULSION, CREAM | 0.25 %W/W |
| TOPICAL | GEL | 0.003 %W/W |